Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05006664
Title Brentuximab Vedotin in Combination With CHEP in Patient With PTCL
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Czech Lymphoma Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CZE


No variant requirements are available.